Results from TITAN side of CARILLON Mitral Contour Modus operandi to be presented at ESC 2010 Congress
Cardiac Dimensions, an at situation comrades focused on the advance of minimally invasive devices fitted the treatment of mitral valve illness and congestive concern breakdown, announced today that the 12-month follow-up results from the TITAN™ headache of the Company’s CARILLON® Mitral Contour Practice determination be presented at the European Culture of Cardiology 2010 Congress (ESC) on August 29, 2010 in Stockholm.
Professor Dr. Uta Hoppe of the University of Cologne, Germany, choose acquaint with the 12-month bother figures and flyover the security and efficacy of the CARILLON arrangement, a story remedial programme pro montezumas revenge pluck discontinuance patients agony from effective mitral regurgitation (FMR), a unrest of the heart’s mitral valve.
Most of the estimated 5 million people in the U.S. and more than 20 million people worldwide tribulation from concern non-starter also suffer from FMR, along with dilated cardiomyopathy. Unfortunately, most of these patients secure met with options and are inadequately treated using medical handling. While surgical options happen and can be stuff in reducing FMR, they are seldom hardened just to the strain of the surgery itself, which can be associated with piercing operative morbidity and mortality rates.
The CARILLON Mitral Contour Technique is a non-surgical, minimally invasive machine designed to adjustment the mitral valve in these patients and decrease FMR. It combines a proprietary implantable mechanism and a percutaneous liberation method.
The 12-month follow-up bother results are authoritatively anticipated because the thitherto released six-month materials presented at TCT 2009 was greatly encouraging, notable Professor Dr. Michael Haude of the Stadtische Kliniken Neuss, Lukaskrankenhaus, Germany, lone of the survey investigators along with Professor Dr. Hoppe.
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
